KR860007255A - 벤조[c]-1,5-나프티리딘의 제조방법 - Google Patents
벤조[c]-1,5-나프티리딘의 제조방법 Download PDFInfo
- Publication number
- KR860007255A KR860007255A KR1019860001804A KR860001804A KR860007255A KR 860007255 A KR860007255 A KR 860007255A KR 1019860001804 A KR1019860001804 A KR 1019860001804A KR 860001804 A KR860001804 A KR 860001804A KR 860007255 A KR860007255 A KR 860007255A
- Authority
- KR
- South Korea
- Prior art keywords
- lower alkyl
- compound
- formula
- hydrogen
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Display Devices Of Pinball Game Machines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 일반식(Ⅱ)의 화합물을 거의 무수상태의 산성 매질중에서 가열하여 R이 수소이고 R1이 산소인 일반식(Ⅰ)의 화합물을 생성하고 임의로는 생성된 화합물을 일반식 NHR2R3의 아민과 반응시켜 R이 수소이고 R1이 -NR2R3인 일반식(Ⅰ)의 화합물을 생성하거나, 임의로는 R이 수소이고 R1이 산소인 일반식(Ⅰ)의 화합물을 일반식 R5-Hal의 화합물(여기서, R5는 저급알킬, 아릴저급알킬 또는 디아릴저급알킬이고, Hal은 브롬, 염소 또는 요오드이다)과 반응시켜 R1이 산소이고 R이 저급알킬, 아릴저급알킬 또는 디아릴저급알킬인 일반식(Ⅰ)의 화합물을 생성하거나, 임의로는 R1이 산소이고 R이 저급알킬, 아릴저급알킬 또는 디아릴저급알킬인 일반식(Ⅰ)의 화합물을 환원시켜 R1이 H2이고 R이 수소인 일반식(Ⅰ)의 화합물을 생성하거나, 임의로는 R1이 H2이고 R이 수소인 일반식(Ⅰ)의 화합물을 일반식 R6COCl의 화합물(여기서, R6는 저급 알킬, 아릴저급알킬 또는 디아릴저급알킬이다)과 반응시켜 R1이 H2이고 R이인 일반식(Ⅰ)의 화합물을 생성하거나, 임의로는 R1이 H2이고 R이 수소인 일반식(Ⅰ)의 화합물을 포름산-아세트산 무수물과 반응시켜 R1이 H2이고 R이인 일반식(I)의 화합물을 생성하거나, 임의로는 R1이 H2이고 R이(여기서, R6은 수소, 저급알킬, 아릴저급알킬 또는 디아릴저급알킬이다)인 일반식(Ⅰ)의 화합물을 환원시켜 R1이 H2이고 R이 -CH2-R6인 일반식(Ⅰ)의 화합물을 생성하고, 임의로는 약제학적으로 허용 가능한 이들의 산 부가염을 형성시켜 일반식(Ⅰ)의 화합물 또는 약제학적으로 허용가능한 이의 산 부가염을 제조하는 방법.상기 식에서,X는 수소, 할로겐, 저급알킬, 저급알콕시, 트리플루오로메틸 또는 하이드록시이고,R은 수소, 저급알킬, 아릴저급알킬, 디아릴저급알킬, 저급알카노일, 아릴저급알카노일, 또는 디아릴-저급알카노일이며,R1은 H2, 산소 또는 -NR2R3그룹 [여기서, R2와 R3는 독립적으로 수소 또는 저급알킬이거나, 그들이 결합되어 있는 질소원자와 함께그룹(여기서, R4는 수소, 저급알킬, 하이드록시-저급알킬, 아릴, 아릴저급알킬, 또는 디아릴저급알킬이다)을 형성한다]이다.
- 제 1 항에 있어서, R이 수소이고, X가 수소 또는 할로겐이며, R1이 산소인 방법.
- 제 2 항에 있어서, 1,4-디하이드로벤조 [C]-1,5-나프티리딘-2(3H)-온을 제조하는 방법.
- 제 1 항에 있어서, R은 수소이고, X는 수소 또는 할로겐이며, R1은 H2또는 -NR2R3그룹[여기서, R2와 R3는 독립적으로 수소 또는 저급알킬이거나, 그들이 결합되어 있는 질소원자와 함께그룹(여기서, R4는 수소 또는 저급알킬이다)을 형성한다]인 방법.
- 제 4 항에 있어서, 1,2,3,4-테트라하이드로벤조 [C]-1,5-나프티리딘을 제조하는 방법.
- 제 4 항에 있어서, 3,4-디하이드로-2-(4-메틸-1-피페라진일)벤조 [C]-1,5-나프티리딘을 제조하는 방법.
- 제 4 항에 있어서, R이 저급알카노일 또는 아릴저급알카노일인 방법.
- 제 7 항에 있어서, 1-(펜아세틸)-1,2,3,4-테트라하이드로벤조 [C]-1,5-나프티리딘을 제조하는 방법.
- 일반식(Ⅶa)의 화합물을 프리이델-크래프츠(Friedel-Crafts) 조건하에 폐환시켜 일반식(Ⅷ)의 화합물을 수득한 다음, 수득한 화합물을 하이드록실아민과 반응시켜 일반식(Ⅱ)의 화합물을 제조하는 방법.상기 식에서,X는 수소, 할로겐, 저급알킬, 저급알콕시, 트리플루오로메틸 또는 하이드록시이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US711327 | 1985-03-13 | ||
US06/711,327 US4652567A (en) | 1985-03-13 | 1985-03-13 | Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement |
Publications (1)
Publication Number | Publication Date |
---|---|
KR860007255A true KR860007255A (ko) | 1986-10-10 |
Family
ID=24857642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860001804A KR860007255A (ko) | 1985-03-13 | 1986-03-13 | 벤조[c]-1,5-나프티리딘의 제조방법 |
Country Status (19)
Country | Link |
---|---|
US (1) | US4652567A (ko) |
EP (1) | EP0197318B1 (ko) |
JP (1) | JPS61212585A (ko) |
KR (1) | KR860007255A (ko) |
AT (1) | ATE52510T1 (ko) |
AU (1) | AU590748B2 (ko) |
CA (1) | CA1248108A (ko) |
DE (1) | DE3671017D1 (ko) |
DK (1) | DK114386A (ko) |
ES (4) | ES8707528A1 (ko) |
FI (1) | FI861001A (ko) |
GR (1) | GR860681B (ko) |
HU (2) | HU201756B (ko) |
IL (1) | IL78117A0 (ko) |
NO (1) | NO163489B (ko) |
NZ (1) | NZ215439A (ko) |
PH (1) | PH22279A (ko) |
PT (1) | PT82187B (ko) |
ZA (1) | ZA861837B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766217A (en) * | 1984-01-13 | 1988-08-23 | Boehringer Ingelheim Kg | Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines |
US5202440A (en) * | 1987-10-05 | 1993-04-13 | Pfizer Inc. | Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines |
WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
US5994367A (en) * | 1997-03-07 | 1999-11-30 | The University Of North Carolina At Chapel Hill | Method for treating tumors using 2-aryl-naphthyridin-4-ones |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2273533A1 (fr) * | 1974-06-04 | 1976-01-02 | Ferlux Sa | Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5 |
US4297358A (en) * | 1979-01-16 | 1981-10-27 | Ciba-Geigy Corporation | Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use |
BE880455A (fr) * | 1979-01-22 | 1980-06-06 | Sandoz Sa | Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine |
-
1985
- 1985-03-13 US US06/711,327 patent/US4652567A/en not_active Expired - Lifetime
-
1986
- 1986-03-07 EP EP86103085A patent/EP0197318B1/en not_active Expired - Lifetime
- 1986-03-07 AT AT86103085T patent/ATE52510T1/de not_active IP Right Cessation
- 1986-03-07 DE DE8686103085T patent/DE3671017D1/de not_active Expired - Fee Related
- 1986-03-11 HU HU885579A patent/HU201756B/hu not_active IP Right Cessation
- 1986-03-11 IL IL78117A patent/IL78117A0/xx unknown
- 1986-03-11 NZ NZ215439A patent/NZ215439A/xx unknown
- 1986-03-11 PH PH33508A patent/PH22279A/en unknown
- 1986-03-11 HU HU861028A patent/HU197007B/hu not_active IP Right Cessation
- 1986-03-11 FI FI861001A patent/FI861001A/fi not_active Application Discontinuation
- 1986-03-11 ES ES552874A patent/ES8707528A1/es not_active Expired
- 1986-03-11 CA CA000503758A patent/CA1248108A/en not_active Expired
- 1986-03-12 NO NO860933A patent/NO163489B/no unknown
- 1986-03-12 GR GR860681A patent/GR860681B/el unknown
- 1986-03-12 DK DK114386A patent/DK114386A/da not_active Application Discontinuation
- 1986-03-12 JP JP61052750A patent/JPS61212585A/ja active Pending
- 1986-03-12 ZA ZA861837A patent/ZA861837B/xx unknown
- 1986-03-12 AU AU54658/86A patent/AU590748B2/en not_active Ceased
- 1986-03-13 KR KR1019860001804A patent/KR860007255A/ko not_active Application Discontinuation
- 1986-03-13 PT PT82187A patent/PT82187B/pt unknown
- 1986-11-17 ES ES557208A patent/ES8800941A1/es not_active Expired
- 1986-11-17 ES ES557207A patent/ES8801269A1/es not_active Expired
-
1987
- 1987-10-15 ES ES557768A patent/ES8801270A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3671017D1 (de) | 1990-06-13 |
EP0197318B1 (en) | 1990-05-09 |
IL78117A0 (en) | 1986-07-31 |
AU590748B2 (en) | 1989-11-16 |
CA1248108A (en) | 1989-01-03 |
HU197007B (en) | 1989-02-28 |
FI861001A0 (fi) | 1986-03-11 |
PT82187B (en) | 1988-01-07 |
ATE52510T1 (de) | 1990-05-15 |
ES557207A0 (es) | 1988-01-01 |
GR860681B (en) | 1986-07-14 |
HU201756B (en) | 1990-12-28 |
AU5465886A (en) | 1986-09-18 |
NO163489B (no) | 1990-02-26 |
HUT40658A (en) | 1987-01-28 |
PH22279A (en) | 1988-07-14 |
ZA861837B (en) | 1987-06-24 |
ES8801269A1 (es) | 1988-01-01 |
ES557208A0 (es) | 1987-12-01 |
ES8800941A1 (es) | 1987-12-01 |
NZ215439A (en) | 1990-03-27 |
JPS61212585A (ja) | 1986-09-20 |
US4652567A (en) | 1987-03-24 |
ES8707528A1 (es) | 1987-08-01 |
ES557768A0 (es) | 1988-01-01 |
ES8801270A1 (es) | 1988-01-01 |
DK114386D0 (da) | 1986-03-12 |
FI861001A (fi) | 1986-09-14 |
NO860933L (no) | 1986-09-15 |
PT82187A (en) | 1986-04-01 |
ES552874A0 (es) | 1987-08-01 |
EP0197318A1 (en) | 1986-10-15 |
DK114386A (da) | 1986-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880001656A (ko) | 1,2,3,3a,8,8a-헥사하이드로-3a,8(및 1,3a,8)-디(및 트리)메틸피롤로 [2,3-b] 인돌 및 이의 제조방법 | |
HU908257D0 (en) | Process for the production of substituted 2-hydroxi-methyl-4-pyridone derivatives | |
EP0330065B1 (en) | Sulfonamide compounds | |
HUT52043A (en) | Process for producing intermediates for producing substituted indolinon derivatives | |
DE3767351D1 (de) | Sialosylceramide und verfahren zu deren herstellung. | |
KR840007012A (ko) | -7카르복시메톡시페닐아세트 아미도 -3-세펨 유도체의 제조방법 및 이를 함유한 항박테리아 제제 | |
GEP19971014B (en) | Process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process | |
KR910004633A (ko) | 신규한 2-옥소-1옥사-8-아자스피로[4,5]데칸 유도체와 이들을 포함하는 약학적 조성물 및 그 제조방법 | |
KR860007255A (ko) | 벤조[c]-1,5-나프티리딘의 제조방법 | |
UA26893C2 (uk) | Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей | |
KR900009608A (ko) | 4.5.6.7-데트라하이드로벤즈이미다졸 유도체 | |
Rovnyak et al. | Tricyclic thiazolo [3, 2‐a] thiapyrano [4, 3‐d] pyrimidines and related analogs as potential anti‐inflammatory agents | |
KR920018030A (ko) | 치환된 이미다졸-2-온의 유도체 및 이의 제조방법 | |
NO883080D0 (no) | Fremgangsmaate for fremstilling av nye cefemforbindelser. | |
US5334591A (en) | Tricyclic thienothiopyran carbonic anhydrase inhibitors | |
KR880000429A (ko) | T-부틸 에르골린 유도체 | |
KR860000267A (ko) | 4(5)-치환된 이미다졸의 제조방법 | |
KR910000744A (ko) | 4,5,5a,6-테트라하이드로-3H-이속사졸로[5,4,3-kl]아크리딘 유도체, 이의 제조 방법 및 약제로서의 이의 용도 | |
ES2033313T3 (es) | Procedimiento de sintesis de azetidinonas. | |
KR860007263A (ko) | 치환된 1,8-나프티리딘온의 제조방법 | |
KR840006645A (ko) | 1-프탈리딜-5-플루오로우라실유도체의 제조방법 | |
KR870007933A (ko) | 3-(1H-테트라졸-5-일) 티에노 [2,3-d] 피리미딘-4(3H)-온 | |
IT1180645B (it) | Intermedi per la sintesi di acidi carbossilici | |
ATE109764T1 (de) | Beta-lactamverbindungen und deren herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |